2016 Accelerator Grants - University of Melbourne

The project team seeks to pioneer a new method for testing cancer drug sensitivity and accelerate more precise Pancreatic Cancer treatment. 100 tumours will have their drug susceptibility predicted from there, and then individually tested against all relevant drugs. This will then allow the team to prioritize our >50+ leads into clinical trials.

• Media Release